InvestorsHub Logo

TheDane

02/28/20 2:28 PM

#283523 RE: tedgoeseast #283521

Karin posted it. It came via email. It might just be a Newsletter to shareholders but don’t know.

“Scientific Rationale for Brilacidin as a Potential Novel Coronavirus (COVID-19) Treatment

As conveyed across the last few weeks, Innovation has received inquiries asking about Brilacidin’s potential to treat the coronavirus (COVID-19) given the urgent worldwide need to find effective treatments for this deadly epidemic.

Please see attached as a PDF an informational overview summarizing the scientific rationale for Brilacidin as a potential coronavirus (COVID-19) treatment.

The Company will keep shareholders apprised of news related to evaluating Brilacidin’s antiviral properties for potentially treating COVID-19, and other viruses, in addition to its core Brilacidin programs, in Ulcerative Colitis and Oral Mucositis.”


https://mcusercontent.com/9ed1a6b082ae8962468007971/files/b1f1cf16-3bf8-469d-8620-74e5f423b79a/IPIX_Brilacidin_Defensin_Mimetics_COVID_19_Overview_Feb_2020_fv_2_.pdf

Luckytouch

02/28/20 3:14 PM

#283541 RE: tedgoeseast #283521

I would hope Leo sent more B to the Regional Lab than is required to analyze its utility against COVID19. Perhaps, in the interest of scientific inquiry, during their lunch hour and before having their twinkies or ring dings, they might sprinkle, anoint, mist a few of those tenacious pathogens that they harbor in their facility. Then just “whisper” the results to Leo. Thank you.